BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15156176)

  • 41. Control of RUNX2 isoform expression: the role of promoters and enhancers.
    Stock M; Otto F
    J Cell Biochem; 2005 Jun; 95(3):506-17. PubMed ID: 15838892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
    J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
    Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
    Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
    Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
    Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
    Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
    Miething C; Grundler R; Mugler C; Brero S; Hoepfl J; Geigl J; Speicher MR; Ottmann O; Peschel C; Duyster J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4594-9. PubMed ID: 17360569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes.
    Telfer JC; Hedblom EE; Anderson MK; Laurent MN; Rothenberg EV
    J Immunol; 2004 Apr; 172(7):4359-70. PubMed ID: 15034051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
    Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of gene expression in peripheral T cells by Runx transcription factors.
    Djuretic IM; Cruz-Guilloty F; Rao A
    Adv Immunol; 2009; 104():1-23. PubMed ID: 20457114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Runx transcription factors and the developmental balance between cell proliferation and differentiation.
    Coffman JA
    Cell Biol Int; 2003; 27(4):315-24. PubMed ID: 12788047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cis element in the recombination activating gene locus regulates gene expression by counteracting a distant silencer.
    Yannoutsos N; Barreto V; Misulovin Z; Gazumyan A; Yu W; Rajewsky N; Peixoto BR; Eisenreich T; Nussenzweig MC
    Nat Immunol; 2004 Apr; 5(4):443-50. PubMed ID: 15021880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
    Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
    Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
    Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
    J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene silencing by the thyroid hormone receptor.
    Eckey M; Moehren U; Baniahmad A
    Mol Cell Endocrinol; 2003 Dec; 213(1):13-22. PubMed ID: 15062570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer.
    Wildt KF; Sun G; Grueter B; Fischer M; Zamisch M; Ehlers M; Bosselut R
    J Immunol; 2007 Oct; 179(7):4405-14. PubMed ID: 17878336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association with the nuclear matrix and interaction with Groucho and RUNX proteins regulate the transcription repression activity of the basic helix loop helix factor Hes1.
    McLarren KW; Theriault FM; Stifani S
    J Biol Chem; 2001 Jan; 276(2):1578-84. PubMed ID: 11035023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RUNX and cancer.
    Ito Y; Osato M; Ito K
    Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S6-7. PubMed ID: 14968716
    [No Abstract]   [Full Text] [Related]  

  • 58. Nomenclature for Runt-related (RUNX) proteins.
    van Wijnen AJ; Stein GS; Gergen JP; Groner Y; Hiebert SW; Ito Y; Liu P; Neil JC; Ohki M; Speck N
    Oncogene; 2004 May; 23(24):4209-10. PubMed ID: 15156174
    [No Abstract]   [Full Text] [Related]  

  • 59. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia.
    Lutterbach B; Westendorf JJ; Linggi B; Isaac S; Seto E; Hiebert SW
    J Biol Chem; 2000 Jan; 275(1):651-6. PubMed ID: 10617663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of VWRPY motif-mediated gene repression by Runx proteins during T-cell development.
    Seo W; Tanaka H; Miyamoto C; Levanon D; Groner Y; Taniuchi I
    Immunol Cell Biol; 2012 Sep; 90(8):827-30. PubMed ID: 22370763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.